Who
Ronald M. Kurtz
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, RxSight.
In numbers
- Trades disclosed
- 43
- Buys
- 2
- Sells
- 5
- Bought
- $2.1M
- Sold
- $7.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Jul 2021
- Last trade
- 5 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —338,819 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —200,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —149,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —338,819 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —200,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —149,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —215,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —254,751 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —173,913 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —96,129 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —161,654 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —215,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —254,751 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —173,913 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —96,129 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —161,654 | filing |
| 2 Sep 2026filed 2 Sep 2026 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $35K5,100 at $6.96 | filing |
| 2 Sep 2026filed 2 Sep 2026 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $35K5,100 at $6.96 | filing |
| 31 Aug 2026filed 2 Sep 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code M | —13,425 | filing |
| 31 Aug 2026filed 2 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —13,425 at $0.00 | filing |
News
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing RulesRXST · manilatimes.net · 24 Oct 2026RxSight Appoints Eye Care Industry Leaders to Drive Commercial TransformationRXST · manilatimes.net · 19 Oct 2026RxSight (NASDAQ:RXST) vs. Coloplast A/S (OTCMKTS:CLPBY) Head to Head AnalysisRXST · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Ronald M. Kurtz; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.